Cancer Detection With the help of Liquid Biopsy

Cancer Detection With the help of Liquid Biopsy – An Insight!

With the rising incidence of chronic and lifestyle diseases in people, the demand for diagnostic tests is also increasing in the healthcare industry. With more and more people dying with cancer every day and more people getting affected, diagnostics services for cancer must be improved. Biopsy is the most common test conducted to check the presence of cancer biomarkers in a body. Based on the type of cancer a patient is suffering from, the doctor performs the biopsy which is suitable for the cancer type.

Normally, a tissue biopsy is considered wherein a sample of the tissue is extracted from the body to test the presence of cancerous biomarkers. However, this is a minimally invasive procedure, a small incision is made to extract the affected tissue from the body. Organizations as on date are conducting extensive research to develop new ways to detect cancer and subsequently identify the ways it can be treated. One such way to diagnose cancer is through liquid biopsy. It is a non-invasive procedure, which can detect the presence of cancer biomarkers in the fluids of the body, such as blood. This test can possibly help in diagnosing the cancer at an early stage and planning the right treatment for it. The non-invasive nature of the test is likely to increase the demand for it, thus, leading to an increase in the overall liquid biopsy market.

A recent market intelligence report was published by BIS Research on liquid biopsy market and what is the growth projected of the market. The report also talks about the trends in the market related to applications, types and the competitive scenario. It also indicates the regions where the liquid biopsy procedure has already been tested and the response it has received.

Important Links:

Request the Sample: https://bisresearch.com/requestsample?id=562&type=download

https://goo.gl/HzEGVN

https://goo.gl/1HNf1v

https://goo.gl/1h6VwW

https://goo.gl/rLkVwv

Comments

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...

ADAS and Autonomous Driving Component Market

As per the recent BIS Research report, the ADAS and autonomous driving component market is segmented into component type, level of autonomy, vehicle type, and region for the purpose of study. These segments are further sub-segmented into various categories. In case of market by component type, it is sub-segmented into camera, radar, ultrasonic sensors, LiDAR, and ECU. The use of LiDAR is increasing rapidly in the market owing to reducing cost of LiDAR sensors and their greater range.

BIS Research ( Business Intelligence and Strategy Research)

Search This Blog